Norepinephrine

arginine vasopressin ; Homo sapiens







111 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
51 17151983 [Arginine-vasopressin in septic and vasodilatorial shock]. 2006 Nov 1
52 15719846 Vasopressin: physiology and clinical use in patients with vasodilatory shock: a review. 2005 Jan 1
53 15774061 Dear vasopressin, where is your place in septic shock? 2005 Apr 1
54 16182977 Low plasma vasopressin/norepinephrine ratio predicts septic shock. 2005 Oct 5
55 12645718 A double-blind randomized trial: prophylactic vasopressin reduces hypotension after cardiopulmonary bypass. 2003 Mar 1
56 12851603 Vasopressin: a new target for the treatment of heart failure. 2003 Jul 1
57 14665508 The effect of vasopressin on gastric perfusion in catecholamine-dependent patients in septic shock. 2003 Dec 1
58 11955542 Terlipressin for norepinephrine-resistant septic shock. 2002 Apr 6 1
59 11960941 Prolonged hypobaric hypoxemia attenuates vasopressin secretion and renal response to osmostimulation in men. 2002 May 1
60 12110505 Abnormal regulation of ENaC: syndromes of salt retention and salt wasting by the collecting duct. 2002 Aug 1
61 12131534 Increased contraction to noradrenaline by vasopressin in human renal arteries. 2002 Jul 6
62 11429329 The effects of vasopressin on systemic hemodynamics in catecholamine-resistant septic and postcardiotomy shock: a retrospective analysis. 2001 Jul 1
63 11573972 Neurotransmitter/neuropeptide interactions in the regulation of neurohypophyseal hormone release. 2001 Oct 1
64 10654495 Arginine vasopressin in the treatment of 50 patients with postcardiotomy vasodilatory shock. 2000 Jan 1
65 10844574 Vasopressin regulation of noradrenaline release within the supraoptic nucleus. 2000 Jun 3
66 11033316 Spatial, cellular and temporal basis of vasopressin potentiation of norepinephrine-induced cAMP formation. 2000 Sep 29 2
67 10072003 The effects of vasopressin on endotoxin-induced attenuation of contractile responses in human gastroepiploic arteries in vitro. 1999 Mar 3
68 10361980 The relationship between activation of phosphoinositide-specific phospholipase C and growth stimulation by Ca2+-mobilizing hormones in hepatocytes. 1999 May 3
69 10512533 Arginine vasopressin in the management of vasodilatory hypotension after cardiac transplantation. 1999 Aug 2
70 10519972 Conducted vasomotor responses in arterioles: characteristics, mechanisms and physiological significance. 1999 Sep 1
71 9580082 Arginine vasopressin enhances sympathetic constriction through the V1 vasopressin receptor in human saphenous vein. 1998 Mar 10 2
72 9732394 Role of vasopressin on adrenergic neurotransmission in human penile blood vessels. 1998 Sep 2
73 9754937 Vasopressin receptors involved in adrenergic neurotransmission in the circular muscle of the human vas deferens. 1998 Aug 14 1
74 9832689 Management of vasodilatory shock after cardiac surgery: identification of predisposing factors and use of a novel pressor agent. 1998 Dec 1
75 9087579 Enhancement by vasopressin of adrenergic responses in human mesenteric arteries. 1997 Mar 2
76 9124549 Arginine vasopressin and baroreflex function after converting enzyme inhibition in normal humans. 1997 Mar 1
77 9386112 A prospective randomized trial of arginine vasopressin in the treatment of vasodilatory shock after left ventricular assist device placement. 1997 Nov 4 2
78 8867047 Arginine vasopressin release by acetylcholine or norepinephrine: region-specific and cytokine-specific regulation. 1996 Apr 2
79 7591009 Suppressing sympathetic activation in congestive heart failure. A new therapeutic strategy. 1995 Nov 1
80 8549062 Potent inhibitory effect of SR 49059, an orally active non-peptide vasopressin VIa receptor antagonist, on human arterial coronary bypass graft. 1995 Nov 1
81 7523633 IL-2 induces vasopressin release from the hypothalamus and the amygdala: role of nitric oxide-mediated signaling. 1994 Oct 3
82 7955585 Effects of DDAVP on renal hemodynamics and renin secretion in subjects with essential hypertension. 1994 Aug 2
83 8071854 Responses to vasopressin and desmopressin of human cerebral arteries. 1994 Aug 1
84 1314337 Neurohypophyseal and pituitary-adrenocortical responses to the alpha 1 agonist methoxamine in humans. 1992 Apr 1
85 1945045 Type-2 astrocytes show intracellular Ca2+ elevation in response to various neuroactive substances. 1991 Jul 22 1
86 2046887 Neural modulation of lysine vasopressin-induced changes of catecholamines in the adrenal medulla of the pigeon. 1991 Jan 1
87 1972647 Neuromodulation: associative and nonlinear adaptation. 1990 May 3
88 2480485 The influence of various degrees of cardiac failure, chronic medical treatment, and acute additional enoximone application on the parameters of the vasopressor system. 1989 1
89 2899848 Relationship of alpha-1- and alpha-2-adrenergic-binding sites to regions of the paraventricular nucleus of the hypothalamus containing corticotropin-releasing factor and vasopressin neurons. 1988 Jun 1
90 3138577 Differential effects of hypothalamic catecholamine depletion on the release of arginine vasopressin and CRF-41 into hypothalamo-hypophyseal portal blood. 1988 Aug 1 1
91 3389390 Effects of infused norepinephrine and angiotensin-II on vasopressin levels in humans. 1988 Jun 1
92 3394838 Increase in vagal activity during hypotensive lower-body negative pressure in humans. 1988 Jul 1
93 3535395 The effect of sodium depletion and potassium supplementation on vasopressin, renin and catecholamines in hypertensive men. 1986 1
94 3827993 Norepinephrine applied in the paraventricular hypothalamic nucleus stimulates vasopressin release. 1986 Sep 3 2
95 3966753 Hyponatremia: a prospective analysis of its epidemiology and the pathogenetic role of vasopressin. 1985 Feb 1
96 3980067 In vitro arterial responses to vasopressin in subjects with a family history of hypertension. 1985 Mar-Apr 1
97 6707922 Evidence for the direct effect of vasopressin on human and goat cerebral arteries. 1984 Mar 3
98 6126864 The median eminence as a model to study presynaptic regulation of neural peptide release. 1982 May-Jun 1
99 6755251 Potential role of increased sympathetic activity in impaired sodium and water excretion in cirrhosis. 1982 Dec 16 1
100 6115571 Neurohumoral control mechanisms in congestive heart failure. 1981 Sep 1